powered by LeadingAge New York
  1. Home
  2. » Topics
  3. » Coronavirus Resources
  4. » Guidance by Service Line
  5. » General
  6. » DOH Guidance
  7. » Outpatient Therapeutics

Outpatient Therapeutics

March 25, 2022

Outpatient Therapeutics

DOH Advisory: Pause in Distribution of Sotrovimab
Read More
March 4, 2022

Outpatient Therapeutics

DOH Advisory: Test Soon and Treat Early to Improve Outcomes from COVID-19
Read More
February 28, 2022

Outpatient Therapeutics

DOH Provides Information to LTC Providers on Accessing Antiviral Therapies

DAL provides information on how to access oral antivirals for treatment of COVID-19.

Read More
February 22, 2022

Outpatient Therapeutics

DOH Letter on Availability of COVID-19 Therapeutics for Long Term Care Pharmacies
Read More
January 24, 2022

Outpatient Therapeutics

Clinical Updates from DOH and CDC

DOH issues new advisory on monoclonal antibody treatment recommendations and new vaccination screening checklist for individuals age 12 and over; CDC issues updated antigen testing guidance.

Read More
January 21, 2022

Outpatient Therapeutics

DOH Advisory on Updated COVID-19 Monoclonal Antibody Treatment Recommendations
Read More
December 31, 2021

Outpatient Therapeutics

NYS Medicaid Policy and Billing Guidance for Pharmacy Reimbursement of COVID-19 Oral Antivirals
Read More
December 29, 2021

Outpatient Therapeutics

NYS Medicaid Policy and Billing Guidance for Reimbursement of COVID-19 Monoclonal Antibody Therapeutic Dispensing or Administration at Pharmacies
Read More
December 27, 2021

Outpatient Therapeutics

DOH Advisory on COVID-19 Oral Antiviral Treatments Authorized and Severe Shortage of Oral Antiviral and Monoclonal Antibody Treatment Products
Read More
December 20, 2021

Outpatient Therapeutics

Prioritization of Anti-SARS-CoV-2 Monoclonal Antibodies for the Treatment and Prevention of Severe COVID-19 During Times of Severe Resource Limitations
Read More
  • view more